A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial.

Nam, JL, Villeneuve, E, Hensor, EM et al. (10 more authors) (2014) A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial. Annals of the rheumatic diseases, 73 (6). 1027 - 1036. ISSN 0003-4967

Abstract

Metadata

Authors/Creators:
  • Nam, JL
  • Villeneuve, E
  • Hensor, EM
  • Wakefield, RJ
  • Conaghan, PG
  • Green, MJ
  • Gough, A
  • Quinn, M
  • Reece, R
  • Cox, SR
  • Buch, MH
  • van der Heijde, DM
  • Emery, P
Keywords: Anti-TNF; DMARDs (biologic); Early Rheumatoid Arthritis; Methotrexate; Adolescent; Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Autoantibodies; Double-Blind Method; Drug Therapy, Combination; Early Medical Intervention; Female; Humans; Immunoglobulin G; Induction Chemotherapy; Male; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Remission Induction; Rheumatoid Factor; Synovitis; Treatment Outcome; Young Adult
Dates:
  • Published: June 2014
  • Accepted: 16 February 2014
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Clinical Musculoskeletal Medicine (LIRMM) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 20 Oct 2015 09:41
Last Modified: 21 Oct 2015 09:00
Published Version: http://dx.doi.org/10.1136/annrheumdis-2013-204882
Status: Published
Publisher: BMJ Publishing Group
Identification Number: https://doi.org/10.1136/annrheumdis-2013-204882
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics